Kedar Deshpande MD in Boston, Massachusetts

Home Massachusetts Boston

Kedar Deshpande MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 800 Washington St in Boston, Massachusetts.

They're a part of the: Pratt Medical Group Inc medical group which has around 270 members. You can call their office at 617-636-5000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended State University Of Ny Upstate Medical University and graduated in 1993 (around 31 years of experience). They are listed as doing telehealth appointments.

Kedar S Deshpande MD Office Phone and Directions

Kedar Deshpande MD
Pratt Medical Group Inc
800 Washington St
Boston, Massachusetts 02111
617-636-5000

Patient Ratings
Please rate your experience with Kedar Deshpande MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 617-636-5000

Enter a starting address:

Healthcare Info for Kedar Deshpande MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: State University Of Ny Upstate Medical University
Graduation Year: 1993
The Primary Medical Specialty for Kedar Deshpande MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 5799683405
NPI #: 1841200961
NPI Created On: 08/09/2006
NPI Last Updated Listed as: 03/20/2018
Primary Taxonomy Code: 207R00000X
License Number:
216521
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Harvard Pilgrim Health Care Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: German, Marathi.

Services and Procedures include:

Measurement and graphic recording of total and timed exhaled air capacity
Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
Measurement of lung diffusing capacity
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes
Critical care delivery critically ill or injured patient
Initial nursing facility visit, typically 35 minutes per day
Initial nursing facility visit, typically 45 minutes per day
Subsequent nursing facility visit, typically 10 minutes per day
Subsequent nursing facility visit, typically 15 minutes per day
Subsequent nursing facility visit, typically 25 minutes per day
Physician telephone patient service, 5-10 minutes of medical discussion
Physician telephone patient service, 11-20 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802137739

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802679221

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802753199

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803081891

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829788307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Respiratory

Name of Drug #1: FASENRA

Open Associated Drug #1: 0310-1730-30

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829974011

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: BREZTRI

Open Associated Drug #1: 0310-4616-12

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 830022489

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: BREZTRI

Open Associated Drug #1: 0310-4616-12

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 830078035

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: BREZTRI

Open Associated Drug #1: 0310-4616-12

Pulmonary Disease Professionals in Boston

1.
Michael Ferrera

330 Brookline Ave
Boston, MA
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc

2.
George Oconnor MD

88 E Newton St
Boston, MA
Evans Medical Foundation Inc

3.
George Oconnor MD

1 Boston Medical Ctr Pl
Boston, MA
Evans Medical Foundation Inc

4.
Elisabeth Riviello

330 Brookline Ave
Boston, MA
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc

5.
Krishna Reddy

55 Fruit St
Boston, MA
Massachusetts General Physicians Organization Inc

6.
Asma Tariq

800 Washington St
Boston, MA
Pratt Medical Group Inc

Providers in Pratt Medical Group Inc

1.Dineli Ahearn

800 Washington St
Boston Ma 02111-1552
Pratt Medical Group Inc
Internal Medicine

2.Anas Ahmed

295 Varnum Ave
Lowell Ma 01854-2134
Pratt Medical Group Inc
Pulmonary Disease

3.Anas Ahmed

800 Washington St
Boston Ma 02111-1552
Pratt Medical Group Inc
Pulmonary Disease

4.Anas Ahmed

585 Lebanon St
Melrose Ma 02176-3225
Pratt Medical Group Inc
Pulmonary Disease

5.Rabia Akhtar

800 Washington St
Boston Ma 02111-1552
Pratt Medical Group Inc
Internal Medicine

6.Harmony Allison

800 Washington St
Boston Ma 02111-1552
Pratt Medical Group Inc
Gastroenterology

View all 270 members of Pratt Medical Group Inc medical group